H2AX, a histone H2A variant, has a key role in the cellular response to DNA double-strand breaks (DSBs). H2AX senses DSBs through rapid serine 139 phosphorylation, concurrently leading to the formation of phospho-(c)H2AX foci with various proteins. However, in the cells with different sensitivity to ionizing radiation (IR)-induced DSBs, still incomplete are those specific proteins selectively recruited by cH2AX to decide different cell fates. Because the abundance of cH2AX indicates the extent of DSBs, we first identified IR-induced dose-dependent H2AX-interacting partners and found that Bcl-2-associated transcription factor 1 (BCLAF1/Btf) showed enhanced association with cH2AX only under high-dose radiation. In acutely irradiated cells, BCLAF1 promoted apoptosis of irreparable cells through disturbing p21-mediated inhibition of Caspase/cyclin E-dependent, mitochondrial-mediated pathways. Meanwhile, BCLAF1 co-localized with cH2AX foci in nuclei and stabilized the Ku70/DNAPKcs complex therein, facilitating non-homologous end joining (NHEJ)-based DSB repair in surviving cells. In tumor cells, BCLAF1 was intrinsically suppressed, leading to formation of anti-apoptotic Ku70-Bax complexes and disruption of Ku70/DNAPKcs complexes, all of which contribute to tumor-associated apoptotic resistance and cell survival with defective NHEJ DNA repair. For the first time, our studies reveal that, based on the extent of DNA damage, BCLAF1 is involved in the cH2AX-mediated regulation of apoptosis and DNA repair, and is a cH2AX-interacting tumor suppressor.
Based on the severity of DNA damage, cells activate specific pathways for cell fate decisions. While an acute ionizing radiation (IR) triggers pro-apoptotic signals in cells with irreparable DNA damage, 1 cells persistently exposed to radiation can become resistant/adapted to double-strand breaks (DSBs), 2 which are with an increased risk of carcinogenesis. However, the pathways/mechanisms that determine defined cell fate remain to be elucidated.
The replacement histone H2AX senses DSBs with rapid phosphorylation of serine 139 (gH2AX), which recruits various proteins associated with DNA damage/repair, cell cycle check points, 3 and so on, to form gH2AX foci indicative of DSBassociated genome instability 4 and premalignant lesions. 3 By using our quantitative proteomics approach, 5, 6 we have identified novel H2AX-associating proteins, revealing new aspects of H2AX in regulating IR-induced cell cycle arrest 7 and nucleosome dynamics. 8 Together with recent findings that changes in H2AX site-specific phosphorylation 9 can selectively modulate cellular apoptosis or survival, 10 we reasoned that H2AX coordinates a post-DSB 'switching' program that chooses specific cell fate-determining pathways by selectively recruiting particular proteins in the cells differentially irradiated with acute versus prolonged IR.
By multiplex quantitative proteomics, 7 we first examined how different H2AX-coordinated complexes are formed in cells exposed to different IR doses. We found the most notable hierarchical clusters of high-dose IR-induced gH2AX interactors were those associated with p53 regulation, apoptosis, or both, among which was BCLAF1, previously implicated in TP53-mediated DDR/apoptosis, 11 and lung development. 12 We then explored the novel function of BCLAF1 in the gH2AX-coordinated cell fate-determining pathways under different radiation conditions including those diverse phenotypes associated with either induction of apoptosis in irreparable cells, or cell survival with active DNA repair, or cell survival toward carcinogenesis. From a systemic viewpoint, for the first time, we have elucidated a mechanistic link between the gH2AX-mediated interaction network and different cell fate-determining pathways that drive cells toward either survival or carcinogenesis following exposure to acute or prolonged IR. Specifically, we revealed how dysregulated BCLAF1 under radio-resistant conditions is associated with an impaired apoptotic feedback loop and ineffective DNA repair.
Results
High-dose IR triggers the recruitment of various proteins associated with apoptosis and p53 regulation to gH2AX foci. Using our AACT-based quantitative proteomic approach 7 ( Figure 1a ), we unambiguously identified multiple IR-induced dose-dependent gH2AX-associating proteins (Supplementary Tables S1 and S2 and Supplementary Figure S1 ). We then performed a domain-based analysis to construct a two-dimensional hierarchical clustering map, wherein many IR-inducible gH2AX-associating proteins grouped either structurally or functionally, further confirming the accuracy of our proteomics data (Supplementary Tables  S2 and S3 and Supplementary Figure S2) . Meanwhile, the data-dependent network analysis 13 of the gH2AX interactome revealed connectivity among multiple proteins known to be associated with either regulation of p53, 14 cell cycle, or apoptosis 15 (Supplementary Figure S3 and Supplementary Table S2 ), suggesting that all of the pathways represented by these gH2AX-docking proteins are interconnected. It caught our special attention that among them, a pro-apoptotic p53 regulator, BCLAF1, 16 previously unknown to interact with H2AX, exhibited enhanced association with H2AX specifically in high-dose-irradiated cells (Figure 1b) . Further, more BCLAF1 was detected in the gH2AX immunoprecipitate pulled down from 10-Gy-irradiated cells compared with those in low-dose or non-irradiated cells, which is consistent with the high-dose-induced increase of gH2AX population in the 'reverse-order' immunoprecipitate pulled down by using anti-BCLAF1 antibody (Figure 1c ), indicating that BCLAF1 directly binds gH2AX in a high-dose IRinducible manner.
High-dose IR triggers the translocation of BCLAF1 to cH2AX foci and an enhanced binding of BCLAF1 to CPE-TP53. Since an apoptotic signal can induce binding of BCLAF1 to a nuclear membrane protein, Emerin, 17 we used immunofluorescence to determine where this high-dosedependent BCLAF1-gH2AX association occurs in situ. In non-irradiated cells, BCLAF1 was distributed widely in the nucleoplasm, clearly separated from the background gH2AX foci. In response to low-dose radiation, few BCLAF1 foci were induced close to the nuclei where gH2AX foci were also located. In the 10-Gy-irradiated pro-apoptotic cells showing significant chromatin condensation (Figure 1d ), more BCLAF1 were co-localized with gH2AX foci close to the nuclear periphery where heterochromatin is located for coordinating either transcriptional regulation or maintenance of chromosome integrity. 18 We next determined whether BCLAF1 is indeed involved in the gH2AX-mediated DSB damage recognition and repair. First, few BCLAF1 and 53BP1 were found co-localized in the 10-Gy-irradiated cells showing a significant chromatin condensation (Figure 1d ), indicating that the dose-dependent translocation of BCLAF1 is highly sensitive to the extent of DSBs and is directly involved in gH2AX-mediated DNA damage response (DDR). Further, in chromatin immunoprecipitation analysis, binding of both BCLAF1 and gH2AX to CPE-TP53 was induced substantially in the 10-Gy-irradiated cells compared with non-treated cells (Figure 2a ). Given BCLAF1 was previously known to positively regulate p53 expression by interacting CPE-TP53 during DNA damage, 11 these observations indicated that gH2AX in the nucleosome, accumulated at DNA damage sites, serves as the scaffold to temporarily assist BCLAF1, a pro-apoptotic transcriptional factor, to get access to CPE-TP53, leading to upregulated p53 mRNA and protein levels in the 10-Gy-irradiated cells (Figure 2b ).
BCLAF1 is involved in p21-dependent cell cycle regulation. p53 is essential in diverse DDR pathways associated with either cell cycle arrest, DNA lesion repair, or induction of apoptosis in cells containing irreparable DNA damage. 14 Specifically, in cell cycle arrest at G 1 phase, p53 enhances transcription of p21 (cip1/waf1) , which in turn inhibits cdk activity.
14 Given the involvement of H2AX in the p53/p21 pathway 19 and the gH2AX-dependence of BCLAF1, we therefore explored the role of BCLAF1 in p53/p21-dependent cell cycle regulation by first examining the effect of BCLAF1 knockdown on expression of p53 and p21. As p53 expression is affected by SV40 large T-antigen present in the 293 T cells in which BCLAF1-H2AX interaction was first identified by proteomics (Figure 1b) , we also studied the effect of shortinterfering RNA (siRNA)-mediated knockdown of endogenous BCLAF1 in other cell lines of normal human fibroblasts (MRC-5 and WI-38), and human osteosarcoma (U2OS), respectively. As shown in Figure 2c , knocking down BCLAF1 slightly attenuated p53 expression in non-irradiated cells and had little effect on the 10-Gy IR-induced p53, but generally led to significant increases in p21 expression in these cell lines, suggesting that BCLAF1 is involved in p21 regulation.
We therefore tested whether BCLAF1 is required for p21-induced cell cycle arrest. In asynchronously growing MRC-5 cells highlighted by the phase-characteristic staining ( Figures  2d and e) , a pronounced G 1 phase accumulation was found, especially in the 10-Gy-irradiated cells with siRNA-mediated BCLAF1 knockdown, while without siRNA treatment the population of G 2 /M phase cells decreased from 25% to 10% (Figure 2c ), the suppression of BCLAF1 promotes both a p21 upregulation and a p21-dependent growth arrest in G 1 .
In a p21-dependent manner, cyclin D1 and E are known as the essential components for regulating the cell cycle at either early G 1 or for late G 1 -to-S transition. 20 Because BCLAF1 was found in a complex that regulates cyclin D1 mRNA stability, 21 we tested if BCLAF1 could regulate the p21-dependent cyclin D1 and E. In the 10-Gy-irradatied cells, cyclin D1 was downregulated, while cyclin E was upregulated. siRNAmediated BCLAF1 knockdown then suppressed more cyclin D1 than that of cyclin E in cells with or without IR (Figure 2g ), indicating that BCLAF1 affects cell cycle progression by regulating the p21-dependent cyclins in early G 1 , which is often dysregulated in human cancers.
22
BCLAF1 is suppressed in radio-resistant cells, and BCLAF1 differentially regulates cyclin E-mediated cell cycle progression in differentlly irradiated cells. Further, we clarified how BCLAF1 regulates diverse DDR to different extents of DNA damage in either non-irradiated cells, or IRresponsive cells irradiated by a high-dose radiation at 10 Gy, and IR-adapted/-resistant cells, which were first primed with 7.5 cGy for 24 h before a second high-dose radiation at 10 Gy (Figure 3a ). These cells under each radiation condition were collected at a single time point with 1 h post irradiation recovery. We observed that the 10-Gy IR-responsive cells displayed a higher propensity for apoptosis indicated by intense DNA fragmentation, whereas the IR-adapted cells were radio-resistant/pro-survival and characterized by significantly reduced DNA fragmentation (Figure 3a) . Because BCLAF1 was found linking to either pulmonary smooth muscle development 23 or tumor suppression, 12 both wildtype p53 human adenocarcinoma A549 cells 16 and p53-deficient lung carcinoma H1299 cells 24 were chosen. Compared with its expression in IR-responsive A549 cells, BCLAF1 was found to be intrinsically suppressed under IRresistant condition with simultaneously induced p53 and p21 Figure 4) also led to similarly increased expression of p53 and p21 but slightly decreased cyclin E in the IR-responsive cells. However, in the same type of A549 cells under IR-resistant condition, siRNA depletion of BCLAF1 correlated with suppressed expression for p53, p21, and cyclin E. Also, compared with IR-responsive cells, the level of cyclin E, which was generally decreased with siRNA knockdown of BCLAF1, showed an increase in the IRresistant A549 cells having already suppressed BCLAF1 (Figure 3b) . Interestingly, in p53-deficient H1299 cells, both activated p21 and reduced cyclin E were accompanied with reduced BCLAF1 either under IR-resistant condition or siRNA BCLAF1 knockdown (Figure 3b) , collectively indicating that in a p53-independent but p21-dependent manner, BCLAF1 differentially regulates the cyclin E-mediated pathways at G 1 /S phase based on the IR-responsive or -resistant nature of the cells.
BCLAF1 negatively regulates the p21-dependent cell cycle arrest in a H2AX-dependent manner. Next, we investigated exactly how BCLAF1 affects the p21-dependent cell cycle in the differentially irradiated cells. First, 82% of the IR-responsive cells with BCLAF1 knockdown, and 91 or 70% of IR-resistant cells without or with BCLAF1 knockdown were retained in G 1 , compared with 60% G 1 retention observed for non-irradiated or other types of irradiated cells (Figure 3c ). This pronounced G 1 retention associated with either siRNAmediated knockdown or IR-resistant downregulation of BCLAF1 was concomitant with an increase of p21 (Figure 3b ). Further, in the irradiated cells, BCLAF1 knockdown led to an approximately two-fold increase of S-phase cells coincident with a reduction of cyclin E, which is generally downregulated in S phase (Figures 3b and c) . Also, in the immunofluorescence analysis of radiation effect on the growth of wild-type A549 cells, we found that the highdose IR-induced chromatin condensation occurred only in IR-responsive cells, indicating their pro-apoptotic nature (Figure 3d and Supplementary Figure S5) . In contrast, under IR-resistant condition we found these cells not only formed the multicellular spheroids characteristic of radio-resistance 25 but also were accumulated more at G1 showing another radio-resistant character 26 ( Figures 3c and d) . Intriguingly, no apparent condensed chromatin was observed in the IR-responsive cells with BCLAF1 knockdown. Further, all types of the cells with BCLAF1 knockdown became widely distributed in a separate manner, and larger cell populations were observed at S phase. 26 This phenomenon of separated distribution was more pronounced in the BCLAF1 knockdown cells under IR-adapted conditions (Figures 3c and d) . Taken together, BCLAF1 is a negative regulator of p21-dependent cell cycle arrest at either G1 or S phase and inhibits a prosurvival-characteristic distribution of the cell population.
In addition to promoting cell cycle arrest, activated p21 was also known to inhibit apoptosis by suppressing the activation of Caspase 8 and pro-Caspase 3. 27 We therefore investigated whether BCLAF1 affects the activation of Caspase 8 and proCaspase 3 by examining the p21 complexes immunoprecipitated from differentially irradiated A549 cells without or with BCLAF1 knockdown (Figure 3e 
Further, in line with previous evidence that overexpression of BCLAF1 induces a pro-apoptotic factor Bax, 12 we found that siRNA-mediated BCLAF1 knockdown led to suppressed Bax expression, which was highly induced by a high-dose IR, along with reduced activity of the Bax-downstream Caspase-9 and Caspase-3 as well as less cleaved PARP1 (a Caspase-3 substrate). These changes were more pronounced in IRresponsive cells than in IR-resistant cells (Figure 3e ). These results collectively indicated that in IR-responsive cells, BCLAF1 has a pronounced role in disrupting the p21-dependent inhibition of activation of Caspase-dependent mitochondrial-mediated apoptotic pathways.
BCLAF1 is a regulator in the gH2AX-mediated repair of DNA DSBs. Based on our findings that BCLAF1 suppression is associated with both the H2AX-mediated p21-dependent cell cycle arrest and radio-resistance (Figure 3b) , we reasoned that depending on the IR-responsive versusresistant nature of the irradiated cells, BCLAF1 selectively regulates both gH2AX-mediated DDR associated with either apoptosis or DSB repair. We first investigated how BCLAF1 affects IR-induced formation of gH2AX foci, since such foci quantitatively correlate with the extent of DNA damage. 28 As shown in Figure 4a , the IR-resistant cancer cells contained much less DSB-indicative gH2AX and 53BP1 foci than those in the 10-Gy-irradiated IR-responsive cells, indicating attenuated DDR in tumor cells to repeated IR. BCLAF1 Figure 4 BCLAF1 regulates the subcellular-specific feedback loop in balancing apoptosis and cell cycle progression and DNA-PKcs regulates the formation of BCLAF1 foci. (a) Effect of BCLAF1 on the formation of DSB-indicative gH2AX and 53BP1 foci. A549 cells were harvested at 1 h after a defined IR and the percentage of gH2AX and 53BP1 foci-positive cells was determined by analyzing 100 randomly chosen cells and the number of gH2AX and 53BP1 foci per cell was determined on a cell-to-cell basis by the quantitative analysis of at least 30 cells randomly chosen as previously described. 32 Error bars represent S.D. of a technical duplicate. **Po0.05, *Po0.01. (Figure 4a ), or with deficient DNA repair, 29 all emphasizing that the central role of BCLAF1 in modulating diverse DDR, the regulation of DSB repair in particular.
BCLAF1 positively regulates both formation of the DNA-PK complex and the Ku70-mediated feedback loop. Our proteomics data showed the DNA-PK complex enhanced its interaction with gH2AX specifically in the 10-Gy-irradiated IR-responsive cells, whereas non-detectable interaction between gH2AX and ATM/ATR was found (Figure 1b and Supplementary Table S1 ). Previous work indicated that the formation of DNA-PK complex has a critical role in various H2AX-mediated DSB repair processes, 30 particularly through non-homologous end joining (NHEJ) occurring at the G 1 /S transition, where Ku70 is a key regulator. 31 Further, BCL-2, which interacts with BCLAF1 in vitro 16 and negatively regulates DSB repair by disruption of the Ku/DNA-PKcs complex. 32 Based on these established links, we first examined whether BCLAF1 affects the integrity of this DNA-PK complex. In Ku70 immunoprecipitates from differentially irradiated cells, siRNA-mediated BCLAF1 knockdown generally led to a weakened association between Ku70 and DNA-PKcs, and to a greater extent in IR-resistant than in IRresponsive cells (Figure 4b ), indicating that BCLAF1 positively regulates Ku70/DNA-PKcs-coordinated DSB repair through NHEJ.
Additionally, previous work indicated that Ku70 mediates a feedback loop selectively modulating the propensity toward apoptosis or cell cycle progression/survival. 33 In this loop, Caspase-3 activated by free Bax cleaves cyclin E to generate an 18-kDa C-terminal fragment, p18-cyclin E, which then complexes with cytosolic Ku70 to liberate the Ku70-bound Bax for inducing mitochondria-mediated apoptosis. 33, 34 Based on our newly established links between BCLAF1 and major loop components, including Ku70, cyclin E, Bax, and Caspase-3 (Figures 3b and e) , we then explored the function of BCLAF1 in this Ku70-mediated feedback loop by comparing the effect of BCLAF1 in formation of the Ku70 complexes under different radiation conditions. Because both cyclin E and DNA-PKcs are mainly localized in the nucleus, whereas Caspase-3 and Bax function in the cytoplasm, 30 our investigation was conducted with subcellular resolution. In nuclei of IR-responsive cells, BCLAF1 knockdown led to an increased association between Ku70 and p18-cyclin E (Figure 4c ), indicating BCLAF1 may negatively regulate the DNA repair process mediated by the nuclear Ku70/p18-cyclin E complex, 33 promoting apoptosis. On the other hand, in the cytosol of BCLAF1-knockdown cells, Ku70 enhanced its binding to Bax but weakened its interaction with p18-cyclin E, suggesting that BCLAF1 is required to release Bax from the anti-apoptotic Ku70-Bax complex in high-dose-irradiated IR-responsive cells. Under IR-resistant condition, cytosolic Ku70 formed a strong complex with Bax but weakened its interaction with p18-cyclin E, while BCLAF1 knockdown affected Ku70 binding to both proteins in a trend similar to wild-type cells (Figure 4c ), indicating inhibition of apoptosis in the IR-resistant cancer cells is caused by the naturally suppressed BCLAF1. Further, BCLAF1 knockdown had little effect on the stability of the Ku70/p18-cyclin E complex in nuclei, suggesting a less active status of Ku-mediated DNA repair with already reduced BCLAF1. Coincidently, in the nuclear Ku70 complexes, BCL-2, showed similar changes in its affinity to Ku70 as to p18-Cyclin E (Figure 4c ), indicating that, under IR-resistant condition with suppressed BCLAF1, p18-Cyclin E may cooperate with nuclear BCL-2 to suppress the NHEJ pathway for DNA repair.
Downregulation of endogenous BCLAF1 is associated with suppressed activity of NHEJ repair. Further, compared with 10-Gy-irradiated cells with a 1-h recovery, an approximately 50% reduction of gH2AX was observed in the IR-responsive cells recovered for 8 h, indicating activated DSB repair under IR-responsive condition (Figure 4d ). However, less than 30% gH2AX reduction was found in similar IR-responsive cells with BCLAF1 knockdown. Under IR-resistant condition, neither a longer recovery time nor BCLAF1 knockdown had any impact on the amount of IR-induced gH2AX, probably due to already suppressed BCLAF1, all collectively confirming the regulatory role of BCLAF1 in NHEJ DNA repair.
DNA-PKcs regulates the formation/translocation of BCLAF1 foci. As DNA-PKcs phosphorylate many substrates involved in NHEJ-based DNA repair, 35 we investigated whether BCLAF1's DNA repair function could also depend on DNA-PKcs. In 10-Gy-irradiated DNA-PKcs þ / À MEF cells, a large number of the IR-induced BCLAF1 foci were found widely distributed in nuclei, including some foci at the nuclear envelope, while few BCLAF1 foci were observed in the nucleoplasm of the 10-Gy-irradiated DNA-PKcs À / À MEFs (Figure 4e ). In contrast, in both DNA-PKcs þ / À and DNA-PKcs À / À MEFs under IR-resistant condition, the numbers of nuclear BCLAF1 foci were all reduced compared with those in IR-responsive cells (Figure 4e) . Clearly, IR induction of BCLAF1 foci requires both DNA-PKcs and cellular sensitivity to radiation. Further, through tandem mass spectrometry experiments, a predominant phosphoserine at 151 with a phosphotyrosine at 150 were unambiguously identified at BCLAF1 isolated from 10-Gy-irradiated Figure 6) . However, compared with that originated from irradiated DNA-PKcs À / À cells, the phosphorylation level of serine 151 at BCLAF1 isolated from wild-type DNA-PKcs
MEFs showed an approximately 30% increase in site occupancy determined by our newly developed label-free quantitation method using peak area and spectral counting ( Supplementary Figures 7 and 8) . Given that serine 151 is located in an RS domain, and such domains are known to regulate subcellular localization 36 (Supplementary Table S4 ), these quantitative MS results suggested that, stimulated by high-dose IR, DNA-PKcs drives BCLAF1 to the nuclear envelope by directly phosphorylating key BCLAF1 RS residue(s). Based on our observations that gH2AX could be co-localized with not only BCLAF1 (Figure 1d ) but also activated DNA-PKcs in the nuclei of 10-Gy-irradiated IR-responsive cells, BCLAF1 may also co-localize with DNAPKcs at the same nuclear location, defining it as a DNA-PKdependent NHEJ repair protein.
Discussion
Although growing numbers of H2AX interactors involving diverse biological processes have been identified, for cells showing different sensitivities to radiation, it is still incomplete as to how exactly H2AX coordinates specific pathways for different cell fates and what co-factors are involved in these pathways. Strategically, not starting with pre-conceived notions, we first conducted a phenotype-specific dissection of IR-induced H2AX-interacting protein network and then performed zoom-in characterization of novel H2AX partners, their H2AX-coordinated interplay on a pathway scale in particular. Technically, by integrating the results from multiple approaches of quantitative proteomics, cell biology, immunoblotting and confocal imaging, we revealed a mechanistic view that in diverse gH2AX-dependent cell fate-determining pathways, an IR-inducible H2AX-associating partner, BCLAF1, has diverse roles in regulating either apoptosis, or cell survival with active DNA repair or carcinogenesis ( Figure 5) .
Given that depletion of Bcl-2 could enhance the DNAbinding activity of the Ku70/DNA-PKcs complex for accelerating DNA repair, 32 our finding that BCLAF1 knockdown causes a reduced association between Ku70 and DNA-PKcs (Figure 4b ) implied that BCLAF1 is required for stability of the DNA-PK complex critical for NHEJ DSB repair. Mechanistically, in the gH2AX interactome induced by a high-dose acute IR, DNA-PKcs is activated to phosphorylate both H2AX and BCLAF1 resulting in the translocation of some BCLAF1 to gH2AX foci in nuclei, where BCLAF1 serves as an inducer for a p53-dependent G 2 /M arrest of irreparable cells as well as a positive regulator of DNA-PK-dependent DNA repair in the surviving cells with DSBs ( Figure 5) . Meanwhile, the remaining BCLAF1 in cytosol is required for the pro-apoptotic side of Figure 5 A mechanistic model illustrating the multiple roles of BCLAF1 in regulation of apoptosis, cell cycle progression, and NHEJ DBS repair. In IR-responsive cells exposed to a high-dose radiation that activates DNA-PKcs, BCLAF1 re-localizes to the nuclear envelope through site-specific phosphorylation by DNA-PKcs and then emerges with gH2AX foci, which in turn stabilizes the Ku70/DNA-PKcs complex for facilitating NHEJ DSB repair. Meanwhile, BCLAF1 regulates both cyclin E and p53/p21-dependent mitochondria-mediated pathway(s) for promoting pro-apoptotic activity of Caspase-3, leading to the generation of an apoptotic amplifier, p18-cyclin E, followed by Ku70-mediated liberation of active Bax. In contrast, in the IR-resistant carcinoma cells BCLAF1 is intrinsically suppressed, leading to weakened Ku70/DNA-PKcs complex but enhanced associations of Ku70/BCL-2/p18-Cyclin E instead, subsequently reducing the activity of DSB repair. In the cytosol, suppressed BCLAF1 could result in more Ku70-bound Bax, which inhibits the formation of pro-apoptotic Ku70-p18-Cyclin E complex Ku70-mediated feedback loop where BCLAF1 promotes Caspase-3-mediated cleavage of cyclin E, and subsequently induces the dissociation of Bax from its complex with Ku70 for the activation of pro-apoptotic Bax.
On the other hand, BCLAF1 was found intrinsically suppressed in tumor cells with natural radio-resistance. Similar to the effects of siRNA-mediated BCLAF1 knockdown, the suppressed BCLAF1 corresponds to less-translocated BCLAF1 in nuclei, affecting the stability of the Ku70/DNAPKcs complex for reduced DNA repair, leading to p21-dependent cell arrest at G 1 phase or reentry to S phase with replicating the errors caused by DSBs. Meanwhile, with less BCLAF1 modulation, the Ku70-mediated Caspase-dependent mitochondrial-mediated apoptotic pathways could be inhibited for developing apoptosis resistance in mis-replicated surviving cells, eventually leading to carcinogenesis. We therefore concluded that BCLAF1 is a gH2AX-dependent tumor suppressor.
On a systems view, our combined results reveals that cell fate decision is made by the gH2AX-coordinated network specifically involving BCLAF1 and DNA-PKcs, illustrating how the balance between tissue protection from repetitive challenges and eliminating irreparable DSBs could be tightly regulated, or altered, or abrogated based on the extent of DNA damage. Radiation treatment and H2AX immunoprecipitation. Stable cells incorporating 13 C 6 -Arg or 13 C 6 15 N 4 -Arg tags were exposed to a g-ray (AECL Gammacell 40 Irradiator) at 7.5 cGy or 10 Gy, respectively, at the dose rate of 0.75 Gy min À 1 followed by 1 h recovery. Approximately 8 Â 10 8 cells of each type were harvested and H2AX complexes were immunoprecipitated as previously described. 7 Mass spectrometry. IP elutes were separated on NuPAGE 4-12% bis-tris gel (Invitrogen). After staining with Coomassie Brilliant Blue, the entire gel lane was cut into contiguous 22 slices. In-gel digestion was performed on each gel slice and the mixture of peptide digests was extracted from gel. For LC-MS/MS analysis, each peptide set was desalted using the house-made C 18 STAGE tips, 37 and then separated with on-line Eksigent nanoLC system coupled to an LTQOrbitrap hybrid mass spectrometer (Thermo Electron, San Jose, CA, USA) which is equipped with a nano-electrospray source (New Objective, Inc., Woburn, MA, USA). The peptides were first loaded on IntegraFrit trapping column (ProteoPep II C18, 300 Å , 5 mm, 100 mm Â 25 mm, New Objective, Inc.) by using mobile phase of 5% acetonitrile (ACN) in 0.1% formic acid (FA). The retained peptides were washed with the same buffer and were separated on a PicoFrit Analytical Columns (ProteoPep II C18, 300 Å , 5 mm, 50 mm Â 100 mm, tip ID ¼ 10 mm, New Objective, Inc.) by applying a multistep gradient of ACN (5% A in 5 min, 5-40% A in 40 min, 40-90% A in 70 min, isocratic gradient 5 min at 90%, 90-5% A in 95 min; solvent A: 0.1% FA; solvent B: 0.1% FA in 95% ACN). The set of MS/MS raw data first converted to DTA files using ThermoElectron Bioworks 3.3.1 was searched against the IPI-human Fasta database using SEQUEST. The parameters for data search included (1) variable modifications allowing mass difference of 80 Da for possible phophorylation and 6, or 10 Da for 13 C 6 -Arg, or 13 C 6 , 15 N 4 -Arg, respectively, (2) tryptic peptides with allowance of two missed cleavages, and (3) top hit(s) with individual cross-correlation over the threshold dependent on precursor charge states. The proteins with at least two peptides detected (Po0.05) were considered as positive identifications. PepQuan software was used for AACT/SILAC-based peptide/protein quantification.
AACT-based quantitation for distinguishing dose-dependent H2AX interactors. For each arginine-containing peptide, a set of three isotope signals spacing by 6 Da and 10 Da were observed as the 'light (L)' isotope peak was originally from the non-irradiated cells, and the 6 Da (M) or 10 Da (H) signals came from the cells irradiated by IR at 7.5 cGy or 10 Gy, respectively. The ratio of any paired heavy versus light isotope signals, that is, M/L or H/L, was then correlated with the IR-induced dose-dependent abundance of individual protein bound to H2AX (bait) (Figure 1b) . With respect to the relative abundance of H2AX in the immunoprecipitate mixture, which was found to be equal at 1 : 1 : 1, we have set a quantitative threshold to distinguish those IR-inducible/induced H2AX-interacting partners from non-specific background. In reference to the criteria previously established by our group, 38 we first found the average relative S.D. (RSD) for quantitative measurements of M/L or H/L ratio was at 8.9% and then used three-fold RSD, which was approximately equal to 30% changes in the H2AX-bound abundances as the threshold. For most of non-specific contaminants, their M/L or H/ L ratios were close to a unity because of their possibly equal distribution in each immunoprecipitate, for example, hnRNPA1, any identified protein with H/L larger than 1.3 or less than 0.7 was indicative of that its association with H2AX was enhanced or weakened upon the radiation at defined dose level.
Label-free quantitation. Label-free quantitation was performed using MS1 peak area as described previously, 39 and total protein quantitation based on MS2 spectral counting was performed via ProteoIQ label-free quantitation software (NuSep, Bogart, GA, USA).
Bioinformatics analysis. PANTHER (http://www.pantherdb.org) and DAVID (http://david.abcc.ncifcrf.gov/) were used to analyze the functional category of the identified proteins. Domain analysis was performed by using similar hierarchical clustering approach 13 with modifications: both interaction and functional domains in each H2AX-binding protein were identified by SMART (Simple Modular Architecture Research Tool) and Pfam (Protein Family Database). A statistical algorithm based on the average-linkage method was used to establish a similarity metric that relates proteins based on the correlation coefficient of their domains, and vice versa. The cluster file was loaded onto Treeview (version 1.60; http:// rana.lbl.gov/EisenSoftware.htm) to generate a 2D branched-tree image including the phylogenic order of proteins and domain entries.
Co-immunoprecipitation and immunoblotting. Nuclear extracts and immunoprecipitates were obtained, separated, and transferred as described previously, 7 The PVDF membranes (Bio-Rad, Hercules, CA, USA) were blotted respectively with a rabbit polyclonal antibody against BCLAF1 (A300-608A, BETHYL laboratories, Inc., Montgomery, TX, USA), and Histone H3S10ph (ab47297, Abcam, Cambridge, MA, USA), and DNA-PKcs (4602), cleaved Caspase-3 (Asp175) (9664), Caspase 8 (4927) and Bax (2772) (Cell Signaling Technology, Danvers, MA, USA) and Cyclin D1 (H-295) (sc-753) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA, USA); goat-polyclonal antibody against b-actin (sc-1615) (Santa Cruz Biotechnology, Inc.) and GAPDH (IMG-3073) (Imgenex Inc., San Diego, CA, USA); mouse monoclonal antibody against FLAG M2 (F1804), BrdU (B8434) and p21 (P1484) (Sigma), gH2AX (ab22551) (Abcam) and, PARP1 (sc-8007), p53 (DO-1) (sc-126), Bcl-2 (C-2) (sc-7382) and Ku70
Semi-quantitative RT-PCR analysis. Total RNA (approximately 2 mg) was isolated by using RNeasy spin column kits (Qiagen, Valencia, CA, USA), and then reverse transcribed into cDNA by using Superscript II reverse-transcriptase (Invitrogen) at 50 o C. Control reactions were performed without template RNA and Superscript II or with no template cDNA. PCR reactions were done with the cDNA generated from 500 ng of total RNA in a 25-ml reaction, in triplicate for each sample. Both p53 and b-actin were amplified by described primer sets. 40 Chromatin immunoprecipitation (ChIP) assay. IR-treated cells were cross-linked at 80% to 90% confluence with 1% formaldehyde, incubated for 15 minutes and then quenched with 0.1 M glycine-PBS for 5 minutes. The collected cells were washed with 50 mM glycine-PBS and harvested. Each ChIP was performed using SimpleChIP Enzymatic Chromatin IP Kit (Cell Signaling). In all, 2% of the cellular extract before immunoprecipitation was used for the input control. DNA was purified by DNA Purification Columns (Cell Signaling). PCR amplification was performed in ChIP fragments using the oligonucleotide sequences described previously. 11 
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